insights_auto
Why is ORX up 2,18%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
4,70 SEK
arrow_upward
+2,18%(+0,10) 1D
30-окт., 17:00:00 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
4,78 SEK
High
4,78 SEK
Low
4,51 SEK
Mkt. cap
164,74 млн
Avg. vol.
140,13 миң
Volume
79,41 миң
P/E ratio
0,22
52-wk high
36,00 SEK
52-wk low
4,51 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
4,78 SEK
High
4,78 SEK
Low
4,51 SEK
Mkt. cap
164,74 млн
Avg. vol.
140,13 миң
Volume
79,41 миң
P/E ratio
0,22
52-wk high
36,00 SEK
52-wk low
4,51 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
MarketWatch
·
32 мүнөт мурун
This cybersecurity stock will be the next to join the S&P 500
WAOW
·
19 мүнөт мурун
Nasdaq suffers worst month in over a year as AI nerves roil markets
Investing.com
·
10 мүнөт мурун
Alset receives Nasdaq notice for non-compliance with minimum bid price rule
Bloomberg.com
·
3 саат мурун
Nasdaq 100 Hits Third Correction of 2026 on Unwinding Tech Stock Bets
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB